BYSTEAP
LIVE

Serial Number

99553116

Owner

Amgen Inc.

Attorney

Elsa D. Lemoine

Filing Date

Dec 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BYSTEAP Trademark

Serial Number: 99553116

BYSTEAP is a trademark filed by Amgen Inc. on December 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Amgen Inc. (18 trademarks)

One Amgen Center Drive
Thousand Oaks, CA 91320-1799

Entity Type: 03

Trademark Details

Filing Date

December 17, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, prostate, pancreatic, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders, including castration resistant prostate cancer; Pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders; Pharmaceutical preparations for use in the treatment of metastatic diseases; Pharmaceutical preparations for treating metabolic diseases and disorders; Pharmaceutical preparations for treating inflammatory and autoimmune diseases and diseases; Pharmaceutical preparations for treating or preventing cardiovascular and cerebrovascular diseases and disorders; Pharmaceutical preparations

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 8, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 8, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2025 NWOS
NEW APPLICATION ENTERED
Dec 17, 2025 NWAP